Showing results (271-280 of 344) with videos related to

Sort By:
Pageof 35
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2016
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung CancerHaa-Na Song, Ki Sun Jung, Kwai Han Yoo, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2015
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerSun Min Lim, Woong Youn Chung, Kee-Hyun Nam, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapyByung Jo Park, Jong Ho Cho, Jung Hee Lee, et al.
Clinical Pharmacology in Drug Development|January 19, 2018
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLCEng-Huat Tan, Wan-Teck Lim, Myung-Ju Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2025
The role of APOBEC in early-stage epidermal growth factor receptor-mutant non-small cell lung cancerHyun Ae Jung, Jinyeong Lim, Yoon-La Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2015
A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or ErlotinibJi Yun Lee, Jong-Mu Sun, Sung Hee Lim, et al.
Cancer|June 26, 2020
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapySehhoon Park, Joonho Shim, Peter G S Mortimer, et al.
European Journal of Immunology|June 9, 2020
MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLCJiae Koh, Youjin Kim, Kyoung Young Lee, et al.
Cancer Research and Treatment|January 6, 2017
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid CancerMin-Young Lee, Bo Mi Ku, Hae Su Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2019
Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)Jang Ho Cho, Sung Hee Lim, Ho Jung An, et al.
Pageof 35